Aug. 28, 2026

Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next

Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next
Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next
The Bloodline with Blood Cancer United Podcast
Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next
Jay Yang, MD

You cannot have progress without research.

In our latest episode, Dr. Jay Yang of the Karmanos Cancer Institute in Detroit, MI, breaks down the essentials of MDS care, from risk-based treatment plans to managing fatigue and exploring promising new therapies. Tune in to find out why the future of MDS treatment is brighter than ever.

CLICK HERE to participate in our episode survey.

Mentioned on this episode:

Additional Blood Cancer United Support Resources:

Episode supported by Bristol Myers Squibb and Taiho Oncology, Inc.

The post Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next first appeared on The Bloodline with Blood Cancer United Podcast.